MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Abaxis Company Profile (NASDAQ:ABAX)

Consensus Ratings for Abaxis (NASDAQ:ABAX) (?)
Ratings Breakdown: 2 Sell Rating(s), 3 Hold Rating(s)
Consensus Rating:Hold (Score: 1.60)
Consensus Price Target: $41.25 (7.82% downside)

Analysts' Ratings History for Abaxis (NASDAQ:ABAX)
Show:
DateFirmActionRatingPrice TargetActions
4/19/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016CL KingInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2016Credit SuisseReiterated RatingUnderperform$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Piper JaffrayLower Price TargetNeutral$49.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Bank of AmericaDowngradeNeutral -> Underperform$66.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Abaxis (NASDAQ:ABAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/21/2016        
4/28/2016Q416$0.32$0.36$56.62 million$57.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q316$0.33$0.35$58.52 million$52.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q216$0.32$0.34$56.20 million$56.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q116$0.28$0.31$53.75 million$53.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q415$0.27$0.17$55.62 million$52.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q315$0.25$0.26$51.70 million$59.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2014Q215$0.23$0.39$50.55 million$53.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q115$0.19$0.21$46.95 million$47.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q414$0.19$0.17$45.74 million$42.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014Q314$0.20$0.14$49.47 million$40.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2013Q114$0.21$0.18$48.60 million$45.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q1 2014$0.23$0.14$49.13 million$43.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q4 2013$0.26$0.30$52.47 million$50.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013Q3 2013$0.20$0.22$45.75 million$49.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2012$0.18$0.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012$0.17$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.16$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012$0.16$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.14$0.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$0.16$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.16$0.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$0.18$0.17ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Abaxis (NASDAQ:ABAX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.27$0.35$0.31
Q2 20162$0.39$0.40$0.40
Q3 20163$0.42$0.44$0.43
Q4 20161$0.39$0.39$0.39
Q1 20171$0.34$0.34$0.34
Q2 20171$0.37$0.37$0.37
Q4 20171$0.40$0.40$0.40
Q1 20181$0.41$0.41$0.41
Q2 20181$0.45$0.45$0.45
Q3 20181$0.42$0.42$0.42
Q4 20181$0.48$0.48$0.48
(Data provided by Zacks Investment Research)
Dividend History for Abaxis (NASDAQ:ABAX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
4/28/2016quarterly$0.121.06%6/1/20166/3/20166/17/2016Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016quarterly$0.111.01%3/1/20163/3/20163/17/2016Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015quarterly$0.110.84%12/1/201512/3/201512/17/2015Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015quarterly$0.110.9%9/1/20159/3/20159/17/2015Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015quarterly$0.110.79%6/2/20156/4/20156/18/2015Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.100.65%2/27/20153/3/20153/17/2015Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014quarterly$0.100.82%11/13/201411/17/201412/16/2014Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014quarterly$0.100.86%8/29/20149/3/20149/17/2014Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014quarterly$0.105/30/20146/3/20146/17/2014Tweet This Announcement  Share This Announcement on StockTwits
12/6/2012special$1.0012/13/201212/17/201212/28/2012Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Abaxis (NASDAQ:ABAX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/9/2016Richard BastianiDirectorSell5,000$46.75$233,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Achim HenkelDirectorSell5,000$44.43$222,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Henk EvenhuisDirectorSell3,000$45.00$135,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Vernon E AltmanDirectorBuy303$39.87$12,080.61View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Craig TockmanVPSell560$54.44$30,486.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Prithipal SinghDirectorSell2,500$60.50$151,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014Kenneth AronCTOSell2,000$56.68$113,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Clinton SeversonCEOSell2,286$56.00$128,016.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Clinton SeversonCEOSell10,000$55.00$550,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2014Clinton SeversonCEOSell10,000$54.00$540,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Alberto Santa InesCFOSell1,652$53.09$87,704.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Clinton SeversonCEOSell5,000$53.00$265,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Clinton SeversonCEOSell10,000$51.50$515,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Richard BastianiDirectorSell1,000$45.40$45,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Alberto Santa InesCFOSell10,738$47.81$513,383.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2014Alberto Santa InesCFOSell17,293$48.01$830,236.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Richard BastianiDirectorSell2,000$42.10$84,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014Richard BastianiDirectorSell4,000$41.88$167,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Achim HenkelDirectorSell8,500$41.63$353,855.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Henk EvenhuisDirectorSell4,000$44.06$176,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Henk EvenhuisDirectorSell4,500$41.00$184,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Vladimir OstoichVPSell9,800$38.53$377,594.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014Kenneth AronCTOSell1,000$38.98$38,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014Donald Peter WoodCOOSell8,864$38.50$341,264.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Clinton SeversonCEOSell10,000$44.50$445,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Martin MulroyInsiderSell14,000$44.80$627,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Kenneth AronCTOSell4,200$43.28$181,776.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2013Achim HenkelDirectorSell5,000$44.07$220,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2013Achim HenkelDirectorSell1,000$42.85$42,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2013Martin MulroyInsiderSell12,000$41.84$502,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2013Kenneth AronCTOSell40,000$44.13$1,765,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Martin MulroyInsiderSell12,000$43.97$527,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2012Richard BastianiDirectorSell5,000$36.60$183,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Abaxis (NASDAQ:ABAX)
DateHeadline
06/24/16 11:53 AMUnleashed: A Wave Of Pet-Friendly Services & Innovations -
06/22/16 07:00 AMPoint of Care Diagnostics Market Worth $20.9 Billion by 2024: Grand View Research, Inc.
06/22/16 07:00 AMVeterinary Diagnostics 2016 Global Market Share,Supply,Consupmtion and Market Opportunities Research Report Forecasting to 2022
06/21/16 10:20 AMABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : June 21, 2016 -
06/20/16 07:34 AMABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : June 20, 2016 -
06/17/16 07:09 PMVeterinary Diagnostics Market Worth 6.71 Billion USD by 2021
06/12/16 02:12 PMGlobal Top 200 Point-Of-Care Diagnostics Companies: Competitive Analysis, Financial Analysis and Strategic Alliance Identification
06/11/16 07:41 PMForm 4 ABAXIS INC For: Jun 08 Filed by: BASTIANI RICHARD
06/10/16 02:13 PMPreventive care testing initiative announced
06/08/16 08:05 PMAbaxis Inc (NASDAQ:ABAX) Partners With AAHA In Preventive Care Program
06/06/16 11:48 AMGlobal Point of Care Diagnostics Market 2016 Analysis and Forecast to 2022
06/06/16 07:00 AMAbaxis Global Diagnostics and AAHA Develop Preventive Care Testing Initiative - [PR Newswire] - Preventive medicine is becoming a cornerstone of practice for general veterinary clinics, making it increasingly important for veterinary professionals to understand the benefit diagnostic testing can have on preventive care and keeping pets healthy. Recognizing the important role diagnostics play in preventive care, the American Animal Hospital Association (AAHA), in conjunction with Abaxis Global Diagnostics, has developed a year-long preventive care testing initiative through the Abaxis Veterinary Consulting Group ("AVC") to educate practitioners about preventive medicine and implementation of preventive medical care programs.
06/02/16 02:13 PMBullish Two Hundred Day Moving Average Cross - ABAX - In trading on Thursday, shares of Abaxis, Inc. (Symbol: ABAX) crossed above their 200 day moving average of $46.98, changing hands as high as $47.00 per share. Abaxis, Inc. shares are currently trading up about 0.4% on the day. The chart below shows the ...
06/01/16 07:23 AMAbaxis, Inc. to Present at the Jefferies 2016 Global Healthcare Conference - [at noodls] - UNION CITY, Calif., June 1, 2016 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary ...
05/31/16 07:55 PMABAXIS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) - The following discussion and analysis should be read in conjunction with our consolidated financial statements and related notes thereto included elsewhere in this Annual Report on Form 10-K. This discussion may contain forward-looking statements based ...
05/31/16 07:55 PMEx-Dividend Reminder: Abaxis, Cott and Bruker - Looking at the universe of stocks we cover at Dividend Channel, on 6/1/16, Abaxis, Inc. (Symbol: ABAX), Cott Corp. (Symbol: COT), and Bruker Corp (Symbol: BRKR) will all trade ex-dividend for their respective upcoming dividends. Abaxis, Inc. will pay its ...
05/31/16 03:59 PMABAXIS INC Files SEC form 10-K, Annual Report -
05/25/16 07:00 AMAbaxis, Inc. to Present at the Stifel 2016 Dental & Veterinary Conference - [PR Newswire] - UNION CITY, Calif., May 25, 2016 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary ...
02/26/16 10:43 AMAbaxis is Oversold - Abaxis, Inc. (ABAX) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors. But making Abaxis, Inc. an even more interesting and ...
02/26/16 10:43 AMEx-Dividend Reminder: Restaurant Brands International, Abaxis and G & K Services - Looking at the universe of stocks we cover at Dividend Channel, on 3/1/16, Restaurant Brands International Inc (Symbol: QSR), Abaxis, Inc. (Symbol: ABAX), and G & K Services, Inc. (Symbol: GK) will all trade ex-dividend for their respective upcoming dividends.
02/12/16 01:59 PMInsider Trading Alert - ABAX, TRNS And EPD Traded By Insiders - Shares are down 30.54% year-to-date as of the close of trading on Thursday. Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide blood constituent ...
02/09/16 04:03 PMABAXIS INC Files SEC form 10-Q, Quarterly Report -
02/04/16 06:44 AMCoverage initiated on Abaxis by Credit Suisse -
02/02/16 09:26 AMABAXIS, Inc. Earnings Analysis: Q3, 2016 By the Numbers -
02/01/16 12:13 PMBiochemistry Analyser Market (2015 – 2021): Report Maps the Qualitative Impact of Various Market Factors on Market Segments and Geographies - Hologic Corporation, Randox Laboratories Ltd., Horiba Medical, ELITechGroup, Rayto Life and Analytical Sciences Co. Ltd., Danaher Corp., Abaxis Inc., Adaltis Inc., Hitachi High-Technologies Corp to name a few. Persistence Market Research (PMR) is an ...
01/29/16 10:52 AMAbaxis down 15% on revenue miss -
01/29/16 10:15 AMAbaxis (ABAX) Beats on Q3 Earnings, Revenues Miss the Mark -
01/29/16 12:58 AMEdited Transcript of ABAX earnings conference call or presentation 28-Jan-16 9:15pm GMT -
01/28/16 07:05 PMBlac Chyna is helping Rob Kardashian with weight loss by cooking him meals and Rose says, "The vibe between them is right " - newratings.com meldet: WASHINGTON - Abaxis Inc (ABAX) revealed a profit for its third quarter that gained ground compared to the same period last year The company said its bottom line rose to $7 96 million, or $0 35 per share . Abaxis Inc. Earnings Advance ...
01/28/16 07:05 PMAbaxis Inc. Earnings Advance 35% In Q3 - (RTTNews.com) - Abaxis Inc. ( ABAX) revealed a profit for its third quarter that gained ground compared to the same period last year. The company said its bottom line rose to $7.96 million, or $0.35 per share. This was higher than $5.89 million, or $0.26 ...
01/28/16 03:47 PMAbaxis tops 3Q profit forecasts -
01/28/16 03:15 PMAbaxis Reports Financial Performance for the Third Quarter of Fiscal 2016, Declares Quarterly Cash Dividend - [at noodls] - , /PRNewswire/ -- (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported ...
01/28/16 03:04 PMABAXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and -
01/28/16 03:03 PM4:03 pm Abaxis beats by $0.02, misses on revs -
01/28/16 06:07 AMQ3 2016 Abaxis Inc Earnings Release - After Market Close -
01/22/16 10:10 AMCardiovascular Q2 Loss Narrower than Expected; Sales Miss -
01/21/16 07:01 AMABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : January 21, 2016 -
01/20/16 07:15 AMAbaxis To Report Third Quarter Fiscal Year 2016 Financial Results On Thursday, January 28, 2016 - [at noodls] - , /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets, has scheduled a conference ...
01/08/16 07:05 AMABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : January 8, 2016 -
01/05/16 07:19 AMAbaxis, Inc. to Present at the 34th Annual J.P. Morgan Healthcare Conference - [at noodls] - , /PRNewswire/ -- (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets worldwide, announced today that ...
12/23/15 03:52 PMABAXIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement -
12/18/15 01:30 PMAbaxis Poised on Balanced Growth and Test Menu Expansion -
12/10/15 07:00 AMAbaxis, Inc. to Present at the Bank of America Merrill Lynch 2015 Animal Health Summit Conference - [PR Newswire] - UNION CITY, Calif., Dec. 10, 2015 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary ...
12/08/15 12:17 PMABAXIS INC Financials -
11/28/15 02:09 PMHedge Funds Are Crazy About Enerplus Corp (USA) (ERF) -
11/24/15 07:00 AMAbaxis, Inc. to Present at the 27th Annual Piper Jaffray Healthcare Conference - [PR Newswire] - UNION CITY, Calif., Nov. 24, 2015 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary ...
11/23/15 07:00 AMAbaxis, Inc. to Place 200 Piccolo Xpress Instruments in the People's Republic of China - [PR Newswire] - UNION CITY, Calif., Nov. 23, 2015 /PRNewswire/ -- Abaxis, Inc. (ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets worldwide, announced today the sale of 200 Piccolo Xpress® instruments to Fuzhou Kelian Medical Devices Ltd ("Kelian"), a laboratory and point-of-care diagnostics distributor based in Fuzhou, China. Kelian will be placing the Piccolo units in neonatal intensive care ("NICU") units, intensive care ("ICU") units, and emergency room ("ER") departments in various provinces throughout the People's Republic of China ("PRC").
11/20/15 07:49 AMHow Abaxis (ABAX) Stock Stands Out in a Strong Industry -
11/17/15 07:54 AMIs Abaxis (ABAX) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat -
About Abaxis

Abaxis logoAbaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company operates through the two segments: the medical market and the veterinary market. The Company's medical market customer group consists of physicians' office practices across multiple specialties, urgent care, outpatient and walk-in clinics, health screening operations, home care providers and nursing homes. The Company's medical market products include: Piccolo chemistry analyzers and consumable products. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ABAX
  • CUSIP: 00256710
Key Metrics:
  • Previous Close: $47.11
  • 50 Day Moving Average: $45.33
  • 200 Day Moving Average: $45.97
  • P/E Ratio: 32.33
  • P/E Growth: 1.80
  • Market Cap: $1.01B
  • Current Quarter EPS Consensus Estimate: $1.41 EPS
Additional Links:
Abaxis (NASDAQ:ABAX) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha